The hybridoma cell line KM50 originally produces a monoclonal antibody at a concentration of |40 mg ml in ascites. To investigate the possibility to apply this expression system to the production of useful proteins, the cDNA encoding human granulocyte colony-stimulating factor was inserted by homologous recombination into just downstream of the promoter of the active immunoglobulin heavy chain gene of KM50. Site directed integration of targeting DNAs resulted in the disruption of expression of the immunoglobulin heavy chain proteins with a frequency of 1 in 10 | 100 G418-resistance transfectants. One of the monoclonal antibody-deficient -1 transfectants produced 25 ng ml of granulocyte colony-stimulating factor in the supernatant of its cell culture the number of molecules of which corresponds to that of the monoclonal antibody originally produced by KM50.
The hybridoma cell line KM50 originally produces a monoclonal antibody at a concentration of |40 mg ml in ascites. To investigate the possibility to apply this expression system to the production of useful proteins, the cDNA encoding human granulocyte colony-stimulating factor was inserted by homologous recombination into just downstream of the promoter of the active immunoglobulin heavy chain gene of KM50. Site directed integration of targeting DNAs resulted in the disruption of expression of the immunoglobulin heavy chain proteins with a frequency of 1 in 10 | 100 G418-resistance transfectants. One of the monoclonal antibody-deficient -1 transfectants produced 25 ng ml of granulocyte colony-stimulating factor in the supernatant of its cell culture the number of molecules of which corresponds to that of the monoclonal antibody originally produced by KM50.
-1 However, when this transfectant was injected intraperitoneally, it produced only a 9 mg ml concentration of granulocyte colony-stimulating factor in ascites, which is approximately 3 orders of magnitude less than the monoclonal antibody. This method may be applicable to production of other recombinant proteins, although further optimization in the conditions of production would be needed in order to reach much higher yields.
Introduction
growth hormone and immunoglobulin Fv molecules (Mitchell et al. 1991; Xiang 1992) . One of the challenges created by modern biotechnolTranscription of the immunoglobulin heavy chain ogy is to open the ways to mass production of useful (IgH) gene is mainly regulated by elements within the proteins which are naturally expressed at a very low immunoglobulin heavy chain variable region (VH) level. Immunoglobulin production in myeloma or promoter and the IgH intron enhancer (mE) (Staudt hybridoma cells is very efficient, suggesting that the and Lenardo 1991). Many eukaryotic expression vecimmunoglobulin gene locus on these cells may be tors use these control elements, although the level of adapted to an efficient system for recombinant protein produced recombinant proteins is often lower than production. Indeed, immunoglobulin expression systhat of original IgH proteins which are produced in tem is currently being tested for the production of hybridoma cell lines, indicating that there are probauseful recombinant pharmaceuticals such as human bly additional elements involved in the regulation of IgH gene expression levels (Mocikat et al. 1995; . Theoretically, this approach can be applied to Furebring et al. 1997; Oancea et al. 1997; Chauveau et other genes of interest, e.g. those encoding pharmaal. 1998). Furthermore, the expression of foreign ceutically relevant proteins. genes in transfected cells is generally unpredictable as transgenes are integrated randomly into the host cell genome. In many cases, transgene expression is supMaterials and methods pressed by neighboring chromatin structures or by the repeated nature of the multiple transgene copies presCloning of active VH-gene containing fragment ent at the integration site (Kolb et al. 1999 ). Therefore, we have sought to specifically target a foreign Cloning, subcloning and sequencing of DNA were gene into the IgH locus by homologous recombinacarried out using standard protocols (Sambrook et al. tion. 1989) . Genomic DNA was isolated from the hybridHomologous recombination is an efficient way to oma cell line KM50 that produces the rat anti-HSA introduce foreign genes into a desirable site on the monoclonal antibody. The active rat VH gene-conhost cell genome. This recombination strategy will taining fragment (9.3 kb: containing both the promotautomatically provide the inserted gene with the er and mE) of KM50 was identified as a rearranged appropriate chromatin structure and regulatory eleband in Southern hybridization of XbaI-digested ments required for its abundant expression and overDNAs with mouse JH probe (Maki et al. 1980 ; comes many of the difficulties associated with ran- Bruggemann et al. 1986) . A DNA fragment purified domly integrated transgenes. To date, homologous from agarose gel was cloned into the XbaI site of recombination in hybridoma cells has been successlZAP (Stratagene, La Jolla, CA). The phage library of fully used to direct the production of fusion proteins these genomic DNAs was screened with the mouse JH consisting of a monoclonal antibody with mouseprobe. The DNA sequences of the promoter and the human chimeric antibody chains (Fell et al. 1989;  coding regions of the active VH of KM50 are deKardinal et al. 1995; Mocikat et al. 1997) . For examscribed in Figure 1 . ple, the murine hybridoma cell line L20 was targeted at the active immunoglobulin heavy chain constant Construction of targeting vectors region (CH) locus with a vector containing human Cg1 gene and the transformed clone produced almost
The structure of the targeting vectors is described in the same amount of mouse-human chimeric antibody Figure 2 . Briefly, to produce a unique SalI site at just as its original murine antibody in cell culture (Fell et the downstream region of the active VH promoter, the al. 1989). To our knowledge, however, there has been cloned rat VH gene was first deleted with BAL31 no study investigating whether heterologous proteins nuclease from the NcoI site at the initiation codon other than antibodies could be produced in the similar ATG and ligated with a SalI linker. This SalI site is amounts to original monoclonal antibodies in hybridused for insertion of heterologous genes. The HindIII oma cells.
site in the first intron between exon 1 (leader exon: L KM50 is a hybridoma cell line which produces a rat exon) and exon 2 (VDJ) of the VH gene was conanti-human serum albumin (HSA) monoclonal antiverted to the ClaI site with a linker. The vector body (IgG1) (Yoshida et al. unpublished results) . pHoKM17 allows the expression of neomycin R KM50 yields a large amount of this monoclonal resistance / G418 (NEO) gene under the control of -1 antibody, in optimal conditions reaching 40 mg ml KM50 active IgH promoter. A 1.7 kb fragment conin ascites fluid. Therefore, this prompts us to study taining both the NEO gene and the polyadenylation whether this expression system may be applicable to signal of the herpes simplex virus thymidine kinase efficient production of heterologous proteins.
gene (Atk), derived from pAGE103 (Mizukami and In the present study, we tried to insert human Itoh 1987), was inserted into the SalI -ClaI to replace granulocyte colony-stimulating factor (G-CSF) the L exon of the active VH gene of KM50. To R cDNA into the active IgH locus of KM50 as a model increase the frequency of G418 transfectants, the case, because G-CSF is a practically useful cytokine sequence flanking the translation initiation codon which has been successfully used to treat neutropenic ATG of the NEO gene was changed to the best patients in a variety of clinical situations (Nagata et al. context for the initiation reported by Kozak (1986 Kozak ( , 1986 Komatsu et al. 1987; Kuga et al. 1989 ; Moore 1991) with a synthetic SalI site-and ATG codon- containing oligonucleotide 59-GTCGACCATGG-39. Atk were inserted into the SalI and the ClaI sites to A fragment (1.1 kb) containing mE is deleted by replace the L exon of the active VH gene of KM50. digestion with EcoRV. The vector pHoKM18 is simiThe vector pHoKM24LRCSF21 is similar to lar to pHoKM17 except for containing the mE region.
pHoKM23LRCSF21 except containing the mE. The vector pHoKM23LRCSF21 was constructed as follows. To install a drug selection marker, a 2
Transfection of targeting DNAs kbEcoRV-BamHI fragment of pAGE28 (Mizukami and Itoh 1987) (containing the tandem promoter
The DNA of either targeting vector was linearized by sequences consisting of pBR322 P1 promoter and the XbaI and EcoRV digestion. The DNA fragment conherpes simplex virus thymidine kinase gene promoter, taining the IgH promoter and heterologous genes was NEO gene and Atk) was inserted into the BglII site isolated from agarose gel and used for transfection (located in the upstream region of KM50 active VH experiments described below. Two mg of the DNA 6 promoter) using a BglII linker. The first PstI site from fragment and 2 3 10 KM50 cells were used for each the initiation codon ATG at the 59 non-coding region transfection. Transfection was carried out by elecand DraI site at the 39 non-coding region of the troporation using a Gene Pulser apparatus (Bio-Rad G-CSF cDNA (0.7 kb) (Nagata et al. 1986 ; Komatsu laboratories, Richmond, CA) at 200 V and 250 mF. et al. 1987) were converted to SalI sites using SalI After the transfection, cells were plated into 96-well 4 linkers. A DNA fragment encoding the Atk was tissue culture plates at a density of 10 cells / well. The derived from a 0.6 kb pHSG274 SmaI-HindIII fragselection agent G418 (Gibco BRL, Gaithersburg, ment (Brady et al. 1984) . Both the SmaI and the MD) was added 48 hr later at a final concentration of -1 R HindIII sites were changed to SalI and ClaI sites with 0.5 mg ml . G418 transfectants were obtained and the linkers, respectively. Both the 0.7 kb SalI fragrecloned. After the wells became confluent with the ment which encodes the whole coding region of Grecloned cells, supernatants were assayed for the CSF and the 0.6 kbSalI-ClaI fragment containing the expression of the anti-HSA monoclonal antibody and 10 mg ml HSA (SIGMA, Missouri, U.S.A.) at 4 8C. the plates were blocked with 100 ml of 1% BSA-PBS. After removal of the HSA solution, 50 ml of growth Fifty ml of growth medium samples from transfecmedium samples from transfectants or diluted-ascites tants or diluted-ascites fluids of the nude mice confluids of the nude mice containing the anti-HSA taining G-CSF at various concentrations were then monoclonal antibody KM50 at various concentrations added to the wells and incubated overnight at 4 8C. were added to the wells and incubated overnight at After these were washed with Tween-PBS, 50 ml (10 -1 4 8C. After these were washed with Tween-PBS, 50 mg ml ) of the mouse anti-human G-CSF mono--1 ml (10 mg ml ) of horseradish peroxidase-conjuclonal antibody KM341 (Yoshida and Shitara 1989) gated rabbit anti-mouse immunoglobulins (DAKO was added to each well as the second antibody and Japan Co., Ltd., Kyoto, Japan) was added to each well incubated overnight at 4 8C. Horseradish peroxidaseand then washed four times with Tween-PBS. 3,39-labeled rabbit anti-mouse immunoglobulins (DAKO diaminobenzidine tetrachloride / nickel-cobalt kit Japan Co., Ltd.) were used as the third antibody. (ZYMED Laboratories, INC. CA, U.S.A.) was used
Plates were then washed four times with Tween-PBS. for the detection. For quantification of the anti-HSA 3,39-diaminobenzidine tetrachloride / nickel-cobalt kit monoclonal antibody, the purified monoclonal anti-(ZYMED Laboratories, INC.) was used to produce a body KM50 was used as a standard. Total protein color change. For quantification of G-CSF, purified recombinant G-CSF (Kuga et al. 1989) The vector pHoKM17 is enhancerless, so that fewer analyzed by 10% sodium dodecyl sulfate-polyrandom insertions can express sufficient amount of acrylamide gel electrophoresis (SDS-PAGE) under the NEO gene at a sufficiently high level to confer reducing condition. The protein bands were visualized resistance to G418. If the targeted locus provides the with Coomassie Blue R-250. Western blotting for the R missing enhancer activity, the fraction of G418 detection of KM50 immunoglobulins or G-CSF was transfectants that were targeted would be greater than performed as described previously (Yoshida and Shifor the enhancer positive vector pHoKM18. Both tara 1989). Briefly, growth medium samples (20 ml) vectors have 6.1 kb of homology on the 59 side, or ascites samples (2 ml each) were separated by whereas 2.1 kb and 3.1 kb of homologies on the 39 SDS-PAGE, and transferred to nitrocellulose memside of the inserted NEO-Atk gene are present in branes. For the detection of the immunoglobulins, pHoKM17 and pHoKM18, respectively. membranes were incubated with peroxidase-conjuWe have tested the efficiency of this technique for gated rabbit anti-mouse immunoglobulins. For the enriching targeted recombination in the VH locus. detection of G-CSF, the membranes were incubated -1
When we used the donor DNA fragment derived from with the monoclonal antibody KM341 (10 mg ml ), R pHoKM18, 190 G418 colonies were obtained. On followed by incubation with horseradish peroxidase-R the other hand, only 90 G418 colonies were obtained conjugated rabbit anti-mouse IgG (DAKO Japan Co., even when fourfold the number of cells were treated Ltd.). The immunoreactive bands were visualized with the donor DNA fragment of pHoKM17 under with a 3,39-diaminobenzidine tetrachloride / nickelsimilar conditions (Table 1) . These results demoncobalt kit (ZYMED Laboratories, INC.).
strate that the enhancerless NEO gene construct re-R duces the number of G418 transfectants by |10-fold compared to that obtained with the enhancer-bearing Results and discussion NEO gene construct. This reduction supports our expectation that the enhancerless gene will only be Structures of KM50 active VH genomic DNA expressed at a restricted number of loci. Site directed integration into the active IgH locus of The genomic library of KM50 was generated and the KM50 should be expected to result in deficiency of active VH gene was cloned. The nucleotide sequence the anti-HSA monoclonal antibody production. To of the VH was determined. As shown in Figure 1 , the test whether the vectors had integrated into the IgH cloned 9.3 kb-XbaI fragment contains the whole locus, we assayed by ELISA the culture medium of 69 R coding sequence of the VH and mE. The active VH G418 transfectants which were transfected with the gene of KM50 is composed of VDJ2 recombination donor DNA fragment of enhancerless vector with the V segment belonging to rat VH-1B family pHoKM17. Figure 3 shows, 7 of 69 transfectants (Bruggemann et al. 1986; Kabat et al. 1987) . There is produced no anti-HSA monoclonal antibody. Furthera octamer sequence, TATA box and cap site semore, although IgH production in these seven transquences at the 59 non-coding region of the cloned VH fectants was abolished, the IgL production remained gene, indicating that this clone contains the promoter normal both in the medium (Figure 4 ) and in the cell region.
bodies by Western blotting analysis. This suggested that the IgH gene has been knocked out in these cells.
Analysis of recombination events in KM50 cells
These experiments suggest that the hybridoma cell line KM50 is capable of mediating homologous reTo assess the frequency of homologous recombinacombination events at high frequencies and that this tion in KM50, we constructed the targeting vectors feature can be used to modify the IgH locus within the pHoKM17 and pHoKM18 (Figure 2 ). In these vecgenome of KM50 to direct production of heterologous tors, the NEO gene replaces the L exon of the VH proteins. Linearized donor DNAs were transferred by electroporation to KM50 cells, which were then incubated in normal medium. At 2 to 3 days after electroporation, cells were plated in microtiter wells at limiting dilution in selective medium (500 mg of G418 per ml) to measure the frequency R of G418 transfectants. These selected colonies were then assayed for the production of anti-HSA antibody. Numbers are the sum of 5 R 6 independent experiments. * Number of G418 transfectants in 2 3 10 treated cells. ** Number of anti-HSA monoclonal antibody negative R R clones in G418 transfectants. *** 69 colonies of 90 G418 transfectants were assayed for the production of anti-HSA monoclonal antibody by ELISA (Figure 3 ). **** Expected number calculated by mE(2) / mE(1) frequency ratio.
Expression of recombinant G-CSF in cell culture
structed this type of vector by inserting P-NEO-Atk gene in both directions, we could not efficiently Hybridoma cell line KM50 was then tested for the obtain transfectants by the vector which contains production of G-CSF by transfecting human G-CSF theNEO-Atk gene and G-CSF-Atk gene in the same cDNA under the control of KM50 active VH promoter orientation.
R (Figure 2). The P (tandem promoter of herpes simplex
We obtained G418 transfectants with the DNA virus thymidine kinase gene and P1)-NEO-Atk gene fragment of mE containing vector pHoKM24 which served as the selection marker was inserted into LRCSF21. One of those transfectants, [6801, prothe BglII site located in the upstream region of the duced both anti-HSA monoclonal antibodies (almost active VH promoter of KM50. Although we conthe same amount as that produced by KM50) and 
Expression of recombinant G-CSF in ascites
Four transfectants (KM50, [6801, [69155, G-CSF (8.5 ng ml in culture supernatant), suggest-[69159) were then intraperitoneally injected to asing that the donor DNA was not targeted to the IgH sess the amount of G-CSF proteins which those locus.
Using the enhancerless vector transfectants yield in ascites (Table 2) . Ascites depHoKM23LRCSF21, we obtained the anti-HSA antiveloped by KM50 and its transfectants contained body non-producing (HSA(-)) transfectants with the almost same amount of total proteins ranging from R -1 frequency of 5 clones in 656 G418 transfectants. 29-34 mg ml at the concentration. These results The monocloned cells were grown to high density suggest that both clones expanded to the same degree 6 -1 (|10 cells ml ) and their culture supernatants were in the abdominal cavity. Among these clones, clone -1 then analyzed by ELISA and Western blotting to [6801 yielded |10 mg ml at concentration which is assess the production of anti-HSA monoclonal anticomparative to KM50. However, clone [69155 and body and G-CSF. Further analyses revealed that two [69159 produced no anti-HSA monoclonal antiboof the transfectants ([6801, [69155) , that were dies in ascites representing the character of these scored as G-CSF positive in the ELISA, produced it transformed cells in in vitro culture. with the electrophoretic mobility expected for full Surprisingly, both clones of [69155 and [69159 -1 length G-CSF in ascites ( Figure 5) . only produced at the maximum of |9 mg ml GFrom ELISA analysis we estimate that the culture CSF. This is three orders of magnitude lower than the supernatant of the maximum producer clone [69155 level of anti-HSA monoclonal antibody produced by -1 contained |25 ng ml while the low producing trans-KM50. One possible reason for this inefficient pro--1 fectant [69159 yielded |1.2 ng ml (data not duction in vivo is that homologous recombination shown). Because the molecular weight of immunobetween transferred and chromosome DNA might be globulin (150 kd) is one order of magnitude higher incomplete. In this context, however, it is unlikely than that of G-CSF (19 kd), we estimated that the that any such general incompleteness would cause actual amount of G-CSF molecules produced by drastic changes in gene expression, because almost a ( †): died when ascites was collected. Each mouse received a single intraperitoneal injection of 1 3 10 cells in a total volume of 0.5 ml. Animals were tapped, depending on the clinical appearance and rate of ascites production of individual mice, with a maximum of two taps per mouse. The numbers in parentheses indicate the day after the implantation, when the ascites was collected.
comparable number of G-CSF protein molecules to to the production of other recombinant proteins, althat of original KM50 monoclonal antibody was though further optimization of the conditions of procalculated to express in vitro. Another possible reason duction is needed in order to reach much higher yield is that the presence of the NEO gene in the upstream in ascites. of the VH promoter might interfere with promoter activity. In the previous studies by other groups (Sun et al. 1994; Oancea et al. 1997; Mocikat 1999) ,
